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α-Synuclein (α-syn) positive glial cytoplasmic inclusions (GCI) originating in
oligodendrocytes (ODC) are a characteristic hallmark in multiple system atrophy
(MSA). Their occurrence may be linked to a failure of the ubiquitin proteasome system
(UPS) or the autophagic pathway. For proteasomal degradation, proteins need to be
covalently modified by ubiquitin, and deubiquitinated by deubiquitinating enzymes
(DUBs) before proteolytic degradation is performed. The DUB ubiquitin carboxyl-
terminal hydrolase L1 (UCH-L1) is a component of the UPS, it is abundantly expressed
in neuronal brain cells and has been connected to Parkinson’s disease (PD). It interacts
with α-syn and tubulin. The present study was undertaken to investigate whether
UCH-L1 is a constituent of ODC, the myelin forming cells of the CNS, and is associated
with GCIs in MSA. Furthermore, LDN-57444 (LDN), a specific UCH-L1 inhibitor, was
used to analyze its effects on cell morphology, microtubule (MT) organization and
the proteolytic degradation system. Towards this an oligodendroglial cell line (OLN
cells), stably transfected with α-syn or with α-syn and GFP-LC3, to monitor the
autophagic flux, was used. The data show that UCH-L1 is expressed in ODC derived
from the brains of newborn rats and colocalizes with α-syn in GCIs of MSA brain
sections. LDN treatment had a direct impact on the MT network by affecting tubulin
posttranslational modifications, i.e., acetylation and tyrosination. An increase in α-tubulin
detyrosination was observed and detyrosinated MT were abundantly recruited to the
cellular extensions. Furthermore, small α-syn aggregates, which are constitutively
expressed in OLN cells overexpressing α-syn, were abolished, and LDN caused the
upregulation of the autophagic pathway. Our data add to the knowledge that the UPS
and the autophagy-lysosomal pathway are tightly balanced, and that UCH-L1 and its
regulation may play a role in neurodegenerative diseases with oligodendroglia pathology.
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Introduction
A common pathogenic event in various neurodegenerative
diseases is the failure to clear misfolded or aggregated
proteins, which occur as protein inclusions in nerve cells
or glia (Dohm et al., 2008; Jellinger, 2012). The inclusions
often contain cytoskeletal proteins, a variety of heat shock
proteins and ubiquitin, and are characteristic for each type of
disease in composition, shape and size. α-Synuclein (α-syn)
is prominently present in Parkinson’s disease (PD), dementia
with Lewy bodies (DLB) and multiple system atrophy (MSA),
a progressive adult-onset neurodegenerative disease with
autonomic failure, symptoms of parkinsonism and ataxia
(Jellinger and Lantos, 2010; Fernagut et al., 2014). α-Syn
positive glial cytoplasmic inclusions (GCIs) originating in
oligodendrocytes (ODC) are the characteristic hallmarks for
the neuropathological diagnosis of MSA. The causes of α-syn
overexpression and aggregation in ODC are not yet clear,
however, impairments of the proteolytic degradation systems
have been implicated to contribute to pathogenic consequences
(Nixon, 2006; Xilouri and Stefanis, 2011; Richter-Landsberg
and Leyk, 2013). α-Syn can be degraded either by the ubiquitin
proteasome system (UPS) or by macroautophagy, hereafter
referred to as autophagy (Webb et al., 2003; Lee et al., 2004;
Vogiatzi et al., 2008; Riedel et al., 2010; Xilouri et al., 2013).
The UPS and autophagy are closely working together and
their activities need to be carefully balanced. Autophagy may
act as a compensatory mechanism when the UPS is inhibited
(Pandey et al., 2007; Schwarz et al., 2012; Richter-Landsberg
and Leyk, 2013).
Autophagy is the only pathway by which large protein
aggregates and organelles can be disposed of. It involves the
formation and elongation of an isolation membrane, which
sequesters cytoplasmic contents, resulting in an organelle
surrounded by a double membrane, the autophagosome. After
autophagosome fusion with the lysosome, the autolysosome
is formed, where the contents are degraded by lysosomal
enzymes (Nixon, 2006; Lamark and Johansen, 2012; Richter-
Landsberg and Leyk, 2013). Autophagosome formation occurs
throughout the cytoplasm, but to fuse with the lysosome,
autophagosomes need to traffic toward the perinuclear region,
a process requiring intact microtubules (MT) and dynein
(Webb et al., 2004; Köchl et al., 2006). For proteasomal
degradation, irreversibly damaged proteins are covalently
modified by ubiquitin. This process involves a multistep
procedure carried out by three different enzymes, namely
E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating
enzyme) and E3 (ubiquitin ligases) (Schwartz and Ciechanover,
2009; Huang and Figueiredo-Pereira, 2010). Substrates can
be modified by conjugation to a single ubiquitin molecule
or a polyubiquitin chain. K48-linked polyubiquitin chains
generally target proteins for proteasomal degradation, while
K63-linked protein chains are involved in various cellular
processes. These include autophagy, cell sorting, and DNA repair
processes (Todi and Paulson, 2011). The polyubiquitin chain
attached to the protein needs to be removed by proteolysis
before the protein is degraded by the proteasome. This is
achieved by deubiquitinating enzymes (DUBs). DUBs comprise
a large family of enzymes opposing the function of E3
ligases and are important regulators of the ubiquitin system
(Amerik and Hochstrasser, 2004; Komander et al., 2009; Reyes-
Turcu et al., 2009). They prevent ubiquitin degradation in
conjunction with the substrate thereby maintaining ubiquitin
homeostasis. Furthermore, they are critically involved in
regulating protein stability and can modulate kinase cascades
of signal transduction pathways. Their overexpression or
impairment may contribute to neurodegenerative diseases and
to the regulation of cell death and survival (Todi and Paulson,
2011).
We have recently shown that treatment of oligodendroglial
cells with the broad range DUB inhibitor PR-619 caused the
accumulation of ubiquitinated proteins and the formation of
ubiquitin-positive protein aggregates, which colocalize with heat
shock proteins, such as HSP70 and αB-Crystallin (Seiberlich
et al., 2012). PR-619 did not affect proteasomal activity
directly, but chronic inhibition of DUBs led to an overload of
ubiquitinated proteins, which exhausted the UPS and autophagy
was activated possibly as a compensatory mechanism (Seiberlich
et al., 2013). Aggresome like structures were formed around
the MT organizing center and DUB inhibition leads to MT
stabilization similarly to the effects of taxol (Seiberlich et al.,
2012).
Since PR-619 is a pan-inhibitor of DUBs, the question
remained whether specific DUBs exert similar physiological
responses and are involved in oligodendroglial pathology. In
this respect the ubiquitin editing enzyme ubiquitin carboxyl-
terminal hydrolase L1 (UCH-L1) is of interest. UCH-L1 is
abundantly expressed in the brain and so far only has been
examined and identified as a neuronal constituent. It localizes
to synaptic vesicles and co-immunoprecipitates with α-syn
(Liu et al., 2002; Amerik and Hochstrasser, 2004; Cartier
et al., 2012), however, its precise functions remain unclear.
Mutations in the UCH-L1 gene have been connected to PD
and AD, and UCH-L1 has been found in Lewy bodies of PD
and neurofibrillary tangles in patients with AD (Lowe et al.,
1990; Yasuda et al., 2009). UCH-L1 directly interacts with α-
tubulin (Kabuta et al., 2008), and overexpression of UCH-L1
was demonstrated to reduce MT formation in vitro (Bheda
et al., 2010).
As mentioned above, ubiquitin-conjugated proteins
also accumulate in neurodegenerative disorders with glial
pathology, and MSA belongs to the group of synucleinopathies
and has features of Parkinsonism (Jellinger and Lantos,
2010). ODC express α-syn, which aggregates under stressful
conditions such as oxidative stress and proteasomal inhibition
(Richter-Landsberg et al., 2000; Riedel et al., 2009; Pukass and
Richter-Landsberg, 2014). ODC are dependent on an intact
MT network, which is involved in transport processes and
protein aggregate formation (Bauer et al., 2009). The present
study was undertaken to investigate whether UCH-L1 is a
constituent of ODC and associates with GCIs in MSA, and
whether its pharmacological inhibition by LDN-57444 (LDN)
affects cell morphology, MT formation and the proteolytic
degradation system.
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Materials and Methods
Ethics Statement
The care and treatments of animals were in accordance
with the institutional guidelines for animal welfare of the
University of Oldenburg, following the standards described
by the German animal protection law (Tierschutzgesetz).
The mere killing of rats for tissue removal is registered
with the local authorities (Niedersächsisches Landesamt für
Verbraucherschutz und Lebensmittelsicherheit) and reported on
a regular basis as demanded by law but needs no further approval
if no other treatment is applied before killing.
Study Subjects
Tissue samples from MSA- and from PD-cases were obtained
from the Department of Neuropathology, Klinikum Bremen-
Mitte, Germany. They were diagnosed during the period from
1974 to 2006. In this study, we analyzed pontine sections of
two patients with MSA, one patient with PD, and one patient
with an astrocytoma as a control. Brain tissue was fixed in 10%
formalin at time of autopsy, cut into tissue blocks, and processed
in paraffin wax using standard protocols. Tissue blocks were cut
into 3 µm thick sections.
Materials and Antibodies
Cell culture media were from Gibco/BRL (Grand Island,
NY, USA). Poly-L-lysine (PLL) and neutral red (NR) were
purchased from Sigma-Aldrich (Munich, Germany). LDN was
from LifeSensors (Philadelphia, PA, USA). Bafilomycin A1 (Bf)
was purchased from Merck Millipore (Darmstadt, Germany).
For Western blot analysis the following antibodies were used,
the working dilutions are given in brackets: anti α-tubulin
mouse monoclonal antibody (mAb) (1:1,000) and mouse mAb
anti acetylated α-tubulin (1:1,000) were from Sigma-Aldrich
(Munich, Germany). Rabbit polyclonal antibody (pAb) anti
detyrosinated α-tubulin (1:1,000) was from Merck Millipore
(Darmstadt, Germany) and rat mAb anti tyrosinated α-tubulin
clone YL1/2 (1:1,000) was from Santa Cruz (Dallas, TX, USA).
Rabbit pAb anti LC3 (1:500) and rabbit pAb PGP 9.5 against
UCH-L1 (1:1,000) were from abcam (Cambridge, UK). Rabbit
pAb anti green fluorescent protein (GFP) (1:1,000) was from
Invitrogen (Grand Island, NY, USA). Mouse mAb anti Beclin-
1 (1:200) was from nanoTools (Teningen, Germany). SNL-4,
a rabbit pAb made against a synthetic peptide corresponding
to residues 2–12 in human α-syn, was from Dr. Virginia Lee
(Philadelphia, PA, USA). Rabbit pAb anti-myelin basic protein
(MBP) (1:1,000) was a generous gift from Dr. Jean-Marie
Matthieu (University Lausanne, Switzerland). HRP-conjugated
anti-mouse IgG (1:10,000) and anti-rabbit IgG (1:10,000) were
from Jackson ImmunoResearch (West Grove, PA, USA).
For immunohistochemical studies, the following antibodies
were used: Mouse mAb LB509 (1:500) directed against α-syn was
from Invitrogen (Grand Island, NY, USA). Rabbit pAb PGP 9.5
against UCH-L1 (1:100) was from abcam (Cambridge, UK).
Immunohistochemistry
For DAB-staining antigen retrieval was done using Vector
unmasking solution (Vector Laboratories, Burlingame, CA,
USA) according to the manufacturer’s instructions. Endogenous
peroxidase activity was quenched using 1% H2O2 and 50%
methanol in phosphate-buffered saline (PBS). Sections
were blocked in 3% bovine serum albumin (BSA) in PBS
supplemented with 0.2% Triton-X 100 for 1 h at room
temperature. Sections were incubated with primary antibodies
mouse mAb LB509 and rabbit pAb PGP 9.5 diluted in the
blocking solution overnight at 4◦C. After washing, sections were
incubated with biotinylated secondary antibodies (1:100) diluted
in blocking solution for 2 h at room temperature. After washing,
sections were incubated with the Vectastain ABC-complex
(Biologo, Kronshagen, Germany) for 1 h at room temperature.
Bound antibodies were visualized by incubation with DAB-
solution for 5 min. Nuclei were stained with hematoxylin for 5
min. After washing with water, sections were dehydrized and
mounted with D.P.X. (Sigma-Aldrich, Munich, Germany).
Double immunolabeling was carried out after antigen
retrieval using Vector unmasking solution (Vector Laboratories,
Burlingame, CA, USA) according to the manufacturer’s
instructions. Sections were blocked in 3% BSA in PBS
supplemented with 0.2% Triton-X 100 for 1 h at room
temperature. First antibodies (LB509 and PGP 9.5) were diluted
in blocking solution and incubated at 4◦C overnight. After
three washes for 30 min with 0.1 M Tris, pH 7.6, sections were
incubated with Dylight 594-conjugated goat anti-mouse (1:500)
and Dylight 488-conjugated goat anti-rabbit (1:500) secondary
antibodies (Thermo Scientific, Rockford, IL, USA) and with 0.1
µg/ml 4’6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich,
Munich, Germany) diluted in blocking solution for at least 3 h at
room temperature. Autofluorescence was blocked using a 0.3%
Sudan Black B solution in 70% ethanol (Romijn et al., 1999).
Sections were mounted with Mowiol® 4–88 (Sigma-Aldrich,
Munich, Germany).
DAB-staining was analyzed using an Olympus microscope
IX70 with bright-field light sources equipped with a digital
camera. Double labeled fluorescence sections were studied using
a Zeiss epifluorescence microscope (Oberkochen, Germany)
equipped with a digital camera using a plan-neofluar objective
(×100) or a Leica TCS SL confocal laser scanning microscope
(Wetzlar, Germany).
Cell Culture
In this study OLN-93 cells (Richter-Landsberg and Heinrich,
1996), OLN-93 cells stably transfected with the longest tau
isoform and with the wild-type human α-syn, named OLN-
t40-α-syn cells (Riedel et al., 2009), and OLN-93 cells
stably transfected with the longest tau isoform and with the
A53T mutant human α-syn, named OLN-t40-A53T (Riedel
et al., 2009), were used. Additionally, a newly established
cell line, OLN-t40-α-syn cells stably transfected with GFP-
LC3, was used to monitor the influence of the inhibition
of UCH-L1 activity on the autophagic flux. OLN-t40-α-syn
cells were transfected with GFP-LC3 plasmid (InvivoGen,
Toulouse, France) containing the Zeocin resistance gene by
using lipofection with Metafectene® Pro (Biontex, Martiensried,
Germany). After selection in Dulbecco’s modified Eagle medium
(DMEM) containing 600 µg/ml Zeocin, the cells were screened
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for tau, α-syn, and for GFP-LC3 expression by western blot and
indirect immunofluorescence. A stable cell line was established
designated OLN-t40-α-syn-GFP-LC3 cells. Cells were kept in
DMEM supplemented with 10% heat-inactivated fetal bovine
serum (FBS), 2 mM Glutamine, 50 U/ml penicillin (P), and
50 µg/ml streptomycin (S) at 37◦C and 10% CO2 (Richter-
Landsberg and Heinrich, 1996).
ODC were prepared as previously described (Goldbaum and
Richter-Landsberg, 2004). Briefly, primary cultures of glial cells
were prepared from the brains of newborn Wistar rats sacrificed
by decapitation, and ODC were mechanically removed after
10–14 days in culture by shaking the flasks on an orbital lab-
shaker (New Brunswick Scientific, Edison, NJ, USA). ODC
precursor cells were replated on PLL-coated culture dishes
(1.2 × 106 cells/6 cm dish) supplemented with glass cover slips
(Fisher Scientific, Schwerte, Germany). Cells were grown in
serum free DMEM supplemented with 2 mM Glutamine, 50
U/ml penicillin, 50µg/ml streptomycin, 5µg/ml insulin, 5µg/ml
transferrin, and 5 ng/ml sodium selenite (Roche Diagnostics,
Mannheim, Germany) in a 10% CO2 atmosphere for up to
10 days. After 5 days these cultures contain a highly enriched
population of differentiated ODC with a mature morphology.
Neutral Red Assay
To assess the cytotoxic potential of LDN on oligodendroglial
cells, OLN-t40-α-syn cells were plated on PLL-coated 96-
microwell cell culture plates at a density of 3,000 cells per well.
The cells were incubated in DMEM/10% FBS for 24 h. Thereafter
the growth medium was removed and fresh medium (100
µl/well) was added with LDN at the indicated concentrations
and cells were incubated for 18 h. Cells were then washed with
PBS and incubated for 4 h in medium containing NR (0.005%)
(100 µl/well). Damaged or dead cells lose the ability to retain
NR. Cells were washed with PBS and NR was extracted with a
solution of acetic acid (1%) and ethanol (50%) (100 µl/well). The
plate was agitated for 2 h and the absorbance of the extracted dye
was determined in a SpectraCount® Microplate Photometer at
540 nm.Data are expressed as percentage of the untreated control
cells and values represent the means ± SD of 16 microwells each
of at least two independent experiments (n = 32).
Immunoblot Analysis
For the detection of UCH-L1 in human (HB) and rat brain (RB)
0.1 g of brain tissue were homogenized in 1 ml 1 × RIPA (20
mM Tris/HCl (pH 7.5), 150 mM NaCl, 1 mM EGTA, 1 mM
Na2-EDTA, 1% NP-40, 1% sodium deoxycholate, and a mixture
of protease inhibitors (Mini Complete; Roche Diagnostics,
Mannheim, Germany)) by sonification. Homogenates were
supplemented with sample buffer containing 5% SDS and boiled
for 10 min. Dorsal root ganglion (DRG) neurons were cultured
in DMEM 10% FBS + P/S + NGF + B27 supplement for 14
days until they achieved the neuronal phenotype. N2A cells and
astrocytes (AST) were cultured for 3 days or 2 weeks, respectively,
in DMEM/10% FBS.
Cellular monolayers of control and treated cells were washed
with PBS once, scraped off in sample buffer containing 1%
SDS, and boiled for 10 min. Protein contents were determined
according to Neuhoff et al. (1979). For immunoblotting total
cellular extracts (10–30 µg protein per lane) were separated by
one-dimensional SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) using 8.75–11.25% polyacrylamide gels and transferred
to nitrocellulose membranes (Whatman, Dassel, Germany; 0,
2 µm) or to PVDF membranes (BioRad, Hercule, CA, USA)
for the detection of LC3. The blots were saturated with Tris-
buffered saline (TBS) (20 mM Tris, 136.8 mM NaCl, pH 7.5)
containing 5% dry milk and incubated with the individual
antibodies overnight at 4◦C. After washing with TBS with
0.1% v/v Tween 20 (TBS-T), incubation with HRP-conjugated
anti-mouse (1:10,000) or anti-rabbit (1:10,000) antibody was
carried out for 1 h at RT. After washing with TBS-T, blots
were visualized by the enhanced chemiluminescence (ECL)
procedure as described by the manufacturer (Thermo Scientific,
Rockford, IL, USA). All experiments were carried out at least
three times with similar results. Quantitative evaluations of
the immunoblots were carried out by densitometric scanning
and ImageQuant software (Molecular Dynamics, Sunnyvale,
CA, USA).
Immunocytochemistry
Naive OLN-93 cells and OLN-t40-α-syn cells (1.2 × 105 cells/10
cm dish), and OLN-t40-α-syn-GFP-LC3 cells (1.6 × 105 cells/10
cm dish) were cultured on PLL-coated glass coverslips for
72 h in DMEM/10% FBS and P/S and then subjected to
treatment as indicated. Primary ODC (1.2 × 106 cells/6 cm
dish) were cultured for 3 h up to 10 days on PLL-coated glass
coverslips in DMEM without any treatment for investigating
the developmental expression of UCH-L1. After washing with
PBS, cells were fixed and permeabilized with ice-cold methanol
for 7 min or fixed with 3% paraformaldehyde for 15 min
and permeabilized with 0.1% Triton-X 100 for 20 min for
incubating with the anti-α-syn antibody SNL-4. Cells were
washed three times with PBS and incubated for 30 min with
5% BSA in PBS for blocking unspecific binding sites. Cells were
incubated overnight at 4◦C with the following antibodies (the
working dilutions are given in brackets): rabbit pAb anti-α-
syn (SNL-4; 1:500), mouse mAb anti-α-tubulin (1:250), mouse
mAb anti-acetylated α-tubulin (1:250), rat mAb anti-tyrosinated
α-tubulin clone YL1/2 (1:200), rabbit pAb anti-detyrosinated
α-tubulin (Glu-tubulin) (1:200), rabbit pAb PGP 9.5 against
UCH-L1 (1:100), mouse mAb against the chondroitin sulfate
proteoglycan NG2 (Millipore, Billerica, MA, USA; 1:200) as
a marker for oligodendrocyte precursor cells, mouse mAb
anti-2′, 3′-cyclic nucleotide 3′-phosphodiesterase (CNP; Sigma,
Munich, Germany; 1:250) as a marker for mature ODC. After
washing with PBS, cells were incubated for 1 h with Dylight
594-conjugated (1:500) goat secondary antibodies (Thermo
Scientific, Rockford, IL, USA), Dylight 488-conjugated (1:500)
goat secondary antibodies (Thermo Scientific, Rockford, IL,
USA), or fluorescein isothiocyanate-conjugated (1:100) donkey
anti rat antibody (Jackson ImmunoResearch, West Grove, PA,
USA), washed with PBS, and mounted. Nuclei were stained
with 4′, 6-diamidino-2-phenylindole (DAPI; 1.5µg/ml) included
in the mounting medium (Vectashield, Vector Laboratories,
Burlingame, CA, USA).
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For gated Stimulated Emission Depletion (STED) laser
scanning microscopy the Abberior STAR 488-conjugated (1:100)
goat anti mouse secondary antibody (Abberior, Göttingen,
Germany) was used and the cells were mounted with Mowiol®
4–88 (Sigma-Aldrich, Munich, Germany).
Fluorescent labeling was studied using a Zeiss epifluorescence
microscope (Oberkochen, Germany) equipped with a
digital camera using a plan-neofluar objective (×40, ×100).
Additionally the newly established confocal laser scanning
microscopy or gated STED laser scanning microscopy from
Leica (Leica TCS SP5 X microscope (Wetzlar, Germany)) was
used. Images were acquired with a 100× immersion objective
(HCX PL APO 100.0× OIL STEDorange, NA = 1.4) using a
white light laser (confocal laser) with a hybrid detector (HyD) or
the STED laser. STED stacks were deconvolved with theoretical
point spread functions using Huygens Essential deconvolution
software (SVI, Hilversum, Netherlands). Confocal stacks and
STED stacks were processed with ImageJ (NIH, Bethesda, MD,
USA). All experiments were carried out at least three times with
similar results.
RNA Extraction and Reverse Transcription
RNA from ODC (2.7 × 106 cells) was isolated with RNeasy
(Quiagen, Hilden, Germany) as described by the manufacturer
for animal cells. RNA was dissolved in diethylpyrocarbonate
(DEPC)-treated water and quantified by spectrophotometry.
About 1 µg of RNA was used for reverse transcription in a final
volume of 25 µl. First-strand synthesis was performed with 0.5
mM of each dNTP, 0.5 µM each of oligo-dT18, and random
hexamer primer, 5 µl of 5× M-MLV buffer, 25 U RNAsin, and
200 U M-MLV reverse transcriptase (Promega, Madison, WI,
USA). After a denaturation step and incubation at 37◦C for 1
h, the reaction mixture was diluted to 65 µl with DEPC-treated
water and stored at −20◦C. Subsequently, 1 µl was used for
polymerase chain reaction analysis.
PCR and Primers
Primers were synthesized by Biomol (Hamburg, Germany):
rat UCH-L1 5′-CCCTTGGTTTGCAGCTTTAG-3′ (nt
777–796) and 5′-CACATCCAAGGCCGTAACTT-3′ (nt
964–983) (Accession no.: NM_017237). For the analysis
of the MBP gene following primers were used: 5′-
GACCCTCACAGCGACACGGAT-3′ (nt 41–61) and 5′-
CTGCTGAGGGACAGGCCTCTC-3′ (nt 336–356) (Roach
et al., 1983).
Control experiments were carried out with the following
primers for glyceraldehyde-3-phosphate dehydrogenase
(GAPDH): 5′-CCCACGGCAAGTTCAACGGCA-3′ (nt
220–240) and 5′-TGGCAGGTTTCTCCAGGCGGC-3′ (nt
805–825) (Fort et al., 1985). PCR reactions were carried out as
previously described (Goldbaum et al., 2008).
Statistics
Arbitrary units were determined by densitometric scanning of
the individual protein bands, and set in relation to α-tubulin.
Data are expressed as % of the control value, set as 100%. Results
are expressed as mean ± SD from at least three independent
experiments. Statistical evaluation was carried out by Student’s
t-test: *p< 0.05 significant and ***p< 0.001 highly significant.
Results
The Deubiquitinase UCH-L1 is Abundant
in ODC and Associates with GCIs in the Brains
of Patients with MSA
To investigate whether UCH-L1 is a constituent of ODC, primary
cultures of RBODCwere extracted and subjected to immunoblot
procedure, and compared to cellular extracts of HB, RB, DRG,
AST neuronal N2A cells and the oligodendroglial cell line OLN-
93 (OLN, see below). Figure 1A depicts that UCH-L1 is present
in ODC and OLN-93 cells at a lower level than in DRG neurons.
Furthermore RT-PCR analysis and immunoblot procedure were
carried out to assess the regulation of UCH-L1 during culture
maturation (Figures 1B,C). The data demonstrate that UCH-
L1 mRNA is present in ODC, and that the protein level does
not significantly change during in vitro differentiation for up
to 10 days (Figure 1D), while the levels of MBP mRNA and
protein increase during that time. Indirect immunofluorescence
further demonstrates that UCH-L1 immunoreactivity is detected
in the cell soma and throughout the cellular processes and has a
punctuated appearance (Figure 1E).
To test the presence of UCH-L1 in MSA, immunohisto-
chemistry of formalin-fixed, paraffin-embedded brain tissue
sections of two MSA cases, one patient with PD, and one patient
with an astrocytoma as a control with no GCIs was carried out.
Pons tissue was chosen as a brain region undergoing extensive
damage in MSA (Wenning et al., 2008). As opposed to the
control (Figures 2A,B), GCIs occurred in both MSA cases and
were immunostained with antibodies against α-syn and UCH-
L1 (Figures 2C,D). Similarly, corroborating the finding of Lowe
et al. (1990), UCH-L1 immunoreactivity was detectable in Lewy
bodies in PD (Figure 2F). Furthermore a-syn was detectable
in LBs in PD (Figure 2E). Double immunofluorescence
labeling reveals that UCH-L1 colocalizes with α-syn in some
but not all GCIs and in Lewy bodies (Figure 3A), which
was further supported by confocal microscopy (Figure 3B).
Orthogonal projections of confocal sections confirm these results
(Figure 3C). Hence, UCH-L1 is a constituent of GCIs in cases of
MSA and similarly as observed in Lewy bodies is colocalized with
α-syn immunoreactivity.
Inhibition of UCH-L1 by LDN Leads
to MT Reorganization and Stabilization
in Oligodendroglial Cells
To test whether inhibition of UCH-L1 has an influence on
process outgrowth, MT organization and α-syn aggregate
formation, the oligodendroglial cell line OLN-93 stably
transfected with α-syn and theMT associated protein tau, namely
OLN-t40-α-syn cells, was used (Richter-Landsberg andHeinrich,
1996; Riedel et al., 2009). These cells constitutively express small
non-fibrillar α-syn aggregates. Cells were treated with LDN,
which acts as a site-directed inhibitor of UCH-L1 inhibiting
the hydrolase activity (Liu et al., 2003; Gong et al., 2006). To
determine whether LDN exerts cytotoxic effects, cells were
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FIGURE 1 | The deubiquitinase UCH-L1 is expressed in rat brain
oligodendrocytes (ODC). (A) Immunoblot analysis. Cell extracts of
human brain (HB), rat brain (RB), dorsal root ganglion neurons (DRG), N2A
cells (N2A), astrocytes (AST), primary rat brain ODC, and OLN-93 cells
(OLN) were subjected to immunoblot procedure using the antibodies as
indicated on the right. (B) mRNA analysis. ODC were cultured for the
indicated times. mRNA was extracted and subjected to RT-PCR. UCH-L1
was analyzed in relation to Glyceraldehyde-3-phosphate-Dehydrogenase
(GAPDH) and Myelin basic protein (MBP) mRNA. The PCR-products
representing the different mRNAs are marked on the right. (C) ODC were
cultured for the indicated times. Cell extracts were subjected to
immunoblot procedure using the antibodies as indicated on the right.
(D) Quantitative evaluation of the blot shown in (C) was carried out using
ImageQuant software. Data represent the mean ± SD from three
independent experiments. UCH-L1 levels were normalized to α-tubulin and
the total amount of the control was set to 100%. Statistical evaluation was
carried out by Student’s t-test: the differences are not significant.
(E) Indirect immunofluorescent staining. ODC were cultured for 3 or 7
days. Indirect immunofluorescence staining was carried out with
antibodies against the chondroitin sulfate proteoglycan NG2 (a), 2′,
3′-cyclic nucleotide 3′-phosphodiesterase (CNP; d), and UCH-L1 (green).
Nuclei were stained with DAPI (blue). Scale bar: 20 µm.
incubated with increasing concentrations of LDN (10–60 µM)
for 18 h, and NR assay was carried out. Figure 4A depicts that
LDN caused cytotoxic effects in a concentration dependent
manner and that at 40 µM cell viability was determined as
about 60%. This was sustained by microscopical inspection of
the cells after NR uptake indicating that after treatment with
LDN the amount of living cells capable of taking up NR was
greatly impaired (Figure 4B). Furthermore cells appeared with
long cellular processes after LDN (40 µM) incubation. For the
following experiments this concentration was used and cells
were incubated for 18 h.
To further assess the influence of LDN on process outgrowth
and abundance of α-syn aggregates in these cells, indirect
immunofluorescence staining with antibodies against α-tubulin
and α-syn was carried out. Additionally, an antibody against
acetylated α-tubulin (ac-tubulin) was used. Tubulin acetylation is
considered to occur on stable MTs and to be an indicator of MT
stability (Janke and Bulinski, 2011; Perdiz et al., 2011). In control
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FIGURE 2 | α-Synuclein and UCH-L1 are present in Lewy bodies and glial
cytoplasmic inclusions. Immunohistochemistry of pontine sections using
antibodies against α-syn (LB509) and UCH-L1, as indicated on the top, was
carried out. The results reveal that glial cytoplasmic inclusions (arrow heads) and
Lewy bodies (arrows), which do not occur in unaffected brain used as a control
(Co) (A,B), positively stain for α-syn (C,E) and UCH-L1 (D,F). Scale bar: 50 µm.
cells MTs are distributed throughout the soma and cellular
processes and were stained by antibodies against α-tubulin
(Figures 5A,E) and against ac-tubulin (Figures 5C,G). Small
α-syn positive aggregates are seen (Figures 5A,C,E,G), which
are abolished after LDN treatment (Figures 5B,D,F,H). After
inhibition of UCH-L1 activity cellular processes are elongated
and ac-tubulin is mainly prominent within the processes and
not apparent in the soma (Figures 5D,H). This is similarly
observed in naive OLN-93 cells without endogenous α-syn and
tau (Figures 5I–L), and also in OLN cells expressing the A53T
α-syn mutation (data not shown).
To monitor MT organization and the localization of ac-
tubulin within the cellular extensions more closely, confocal
microscopy and STED microscopy (Hein et al., 2008) was
carried out. This shows that under control conditions MTs
labeled with antibodies against α-tubulin are evenly distributed,
while after LDN treatment MTs appear as thick bundles within
the cellular extensions (Figures 6A–D). Figure 6F depicts that
in untreated control cells ac-tubulin is prominent in the cell
soma. However, STED microscopy demonstrates that MTs
are not continuously acetylated, but rather smaller elongated
patches are visible, which are interrupted by small gaps of non-
acetylated tubulin (Figure 6E). After treatment with LDN ac-
tubulin is translocated to the cellular processes and the thick
MT bundles are intensely labeled by antibodies against ac-
tubulin (Figures 6G,H). Ac-tubulin is continuously present
along the MTs and not interrupted by gaps, as seen in untreated
control cells. Hence LDN treatment leads to the recruitment
of ac-tubulin to the cell processes, which may promote MT
stabilization.
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FIGURE 3 | Colocalization of α-synuclein and UCH-L1 in glial
cytoplasmic inclusions and Lewy bodies. (A) Double label
immunohistochemistry of sections of multiple system atrophy (MSA) (a–c)
and Parkinson’s disease (PD) brains (d–f) using antibodies against α-syn
(LB509) and UCH-L1 (PGP 9.5), as indicated on the top. Overlay with DAPI
(blue). Scale bar: 20 µm. (B) Confocal images (one section: 0.3 µm) of a
glial cytoplasmic inclusion (a–c) and a Lewy body (d–f) at a higher
magnification are shown. Scale bar: 5 µm. (C) Three dimensional
reconstructions of confocal images (18 sections in a; 36 sections in b)
corroborate that α-syn and UCH-L1 colocalize in GCIs and LBs (marked by
a yellow cross). Reconstructed orthogonal projections are presented as
viewed in the x-z (bottom) and y-z (right) planes. Scale bar: 5 µm.
Since tubulin acetylation is not strictly associated with stable
MTs, we determined the effect of LDN on the tyrosination
state of tubulin. Detyrosination of α-tubulin stabilizes MTs
indirectly and is an indication of enhanced MT stability (Janke
and Bulinski, 2011). Using antibodies against tyrosinated
and detyrosinated α-tubulin, indirect immunofluorescence
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FIGURE 4 | The specific UCH-L1 inhibitor LDN causes concentration
dependent cell death in oligodendroglial cells. (A) Neutral red (NR)
survival assay of OLN-t40-α-syn cells exposed to increasing concentrations of
LDN. Cells were treated with 0–60 µM LDN for 18 h. Cell viability was
determined by NR uptake. Data are expressed as percentage of untreated
control cells. Values represent the means ± SD of 16 microwells of two
independent experiments (n = 32). *p < 0.05 significant and ***p < 0.001
highly significant. (B) Cells were incubated with 40 µM LDN for 18 h (Co,
untreated control). Thereafter cells were incubated with medium containing
0.005% NR and photographed. Scale bar: 100 µm.
demonstrates that tyrosinated α-tubulin (tyr-tubulin) is
distributed throughout the cell soma and processes in control
cells, while detyrosinated α-tubulin (detyr-tubulin) is mainly
expressed in the cell soma and not at the cellular boundaries
and protrusions (Figures 7Aa,Ba–c). After LDN treatment
detyr-tubulin is almost exclusively concentrated within the long
cellular processes and associated with the thick bundles and
hardly visible in the cell soma (Figures 7Ab,Bd–f). Furthermore,
immunoblot analysis of cell extracts reveals that LDN leads to
an increase of detyr-tubulin of about 44% (±16%) as compared
to the untreated control (Figures 7C,D). In contrast thereto,
the level of acetylated α-tubulin did not increase (Figure 9).
Also, LDN had no influence on tau or tau phosphorylation (data
not shown), and as mentioned above elongation of the cellular
processes was independent of the presence of tau or α-syn and
also seen in OLN-93 cells which do not contain both proteins
(Figures 5I–L).
Inhibition of UCH-L1 Leads to the Clearance
of α-Synuclein Aggregates
In OLN-t40-α-syn cells under control conditions small α-syn
positive aggregates were formed, which were not visible after
treatment with LDN (Figure 5). To assess whether this was
due to the activation of the autophagic pathway, we established
FIGURE 5 | LDN induces reorganization of microtubules and the
clearance of α-synuclein puncta in oligodendroglial cells
overexpressing α-synuclein. OLN-t40-α-syn cells (A–H) or OLN-93 cells
(I–L), not expressing α-syn or tau, were incubated with 40 µM LDN for 18 h
(Co, untreated control). OLN-t40-α-syn cells were subjected to indirect
immunofluorescence staining with antibodies against α-syn (red) and α-tubulin
(α-tub; green) or acetylated α-tubulin (ac-tub; green) (A–H, as indicated),
OLN-93 cells with antibodies against α-tub (red) or ac-tub (red) as indicated.
Nuclei were stained with DAPI (blue). Overlay images are shown. Scale bar: 20
µm.
OLN-t40-α-syn cells stably transfected with GFP-LC3 (MT-
associated protein 1 light chain 3). These cells represent a suitable
model system to assess the amount of GFP-LC3 puncta by
immunofluorescence and to detect the GFP fragments generated
by GFP-LC3 inside the autolysosome by immunoblot procedure
using an anti-GFP antibody (Mizushima et al., 2010; Klionsky
et al., 2012). During autophagosome formation endogenous LC3
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FIGURE 6 | Microtubule bundling and acetylation after LDN treatment:
Confocal and STED microscopy. OLN-t40-α-syn cells were incubated with
40 µM LDN for 18 h (Co, untreated control). Cells were subjected to indirect
immunofluorescence staining with antibodies against α-tubulin (A–D) and
acetylated α-tubulin (E–H). Confocal images (one section: 0.21 µm) and STED
images (one section: 0.13 µm) are shown. Scale bar confocal images (G): 20
µm. Scale bar STED images (H): 5 µm.
is processed to LC3-I, an 18 kDa cytosolic isoform, which is
converted to LC3-II, migrating at 16 kDa. LC3-II is tightly
associated with the autophagosomal membranes and serves as
a marker for autophagosomes. Its amount when normalized to
tubulin or actin correlates with the number of autophagosomes.
Figure 8 demonstrates that after treatment with LDN cells depict
an increased level of GFP-LC3 puncta and similarly to OLN-
t40-α-syn cells cellular processes are elongated and extremely
thin. Furthermore, α-syn aggregates are removed after LDN
treatment (Figure 8B). Next we addressed the question whether
LDN activates the autophagic pathway and the autophagic
flux, which comprises the dynamic process of autophagosome
formation and the delivery to and degradation of the substrates
within the lysosomes. Immunoblot analysis corroborates that
after treatment with LDN the levels of LC3-II and free GFP
are significantly increased, indicating that the autophagic flux
was activated (Figures 9A,B). The level of Beclin-1, which is
involved in the formation of the pre-autophagosomal membrane,
did not change. To further sustain that the autophagic flux is not
impaired, cells were preincubated with the lysosomal inhibitor
bafilomycin A1 (3 nM) alone for 20 h, or for 2 h followed by LDN
treatment (18 h) in the presence of bafilomycin A1. Immunoblot
analysis shows that after the combined treatment the levels
of LC3-II and GFP are significantly higher than after each
compound alone, which indicates that the autophagic flux was
activated (Figures 9C,D). An increase in LC3-II was similarly
observed in oligodendroglial cells not expressing the GFP-
LC3 fusion protein, i.e., OLN-t40-α-syn cells and of OLN-t40-
A53T cells (Figures 9E,F). Hence, LDN activates the autophagic
pathway and prevents the formation of α-syn aggregates in
oligodendroglial cells.
Discussion
UCH-L1 has been suggested to be important for neuronal health
and synaptic stability, and to maintain a sufficient level of mono-
ubiquitin, which is important for synaptic integrity (Todi and
Paulson, 2011). UCH-L1 colocalizes with α-syn in presynaptic
terminals, both proteins interact and have been implicated in
PD (Lowe et al., 1990; Amerik and Hochstrasser, 2004; Yasuda
et al., 2009). Here we show that UCH-L1 is also a constituent of
ODC, themyelin forming cells of the CNS, and can associate with
GCIs in the brains of patients with MSA. Its presence in GCIs
further adds to the knowledge that dysfunctions of the proteolytic
degradation systems and of the ubiquitin dependent pathways
may contribute to intracellular inclusion body formation and
neurodegenerative diseases. Furthermore, our data, using the
specific inhibitor LDN demonstrate that UCH-L1 is critically
involved in maintaining the cellular architecture in particular by
influencing theMT network, and that its inhibition has an impact
on α-syn aggregate formation and activates the autophagic
pathway.
UCH-L1 inhibition in oligodendroglial cells led to the
formation of elongated cellular processes, which were
characterized by the presence of thick bundles of MTs positively
stained by antibodies against acetylated and detyrosinated α-
tubulin. Post-translational modifications of tubulin are critically
involved in MT regulation and stability, process outgrowth
and establishment of cell morphology and maturation. Tubulin
acetylation is considered to occur on stable MTs and may
selectively stimulate intracellular dynamics, and enhance
intracellular vesicular traffic and cargo distribution (Janke and
Bulinski, 2011; Perdiz et al., 2011). In oligodendroglia control
cells ac-tubulin is evenly distributed within the soma and the
cellular processes, however, as demonstrated by high resolution
STEDmicroscopy, interrupted by small gaps. In contrast thereto,
after inhibition of UCH-L1 ac-tubulin is hardly seen in the soma
but prominently expressed in the long cell processes. Here
acetylated MTs are enriched and appeared to be bundled in
the cellular extensions and are continuously immunostained
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FIGURE 7 | Effects of LDN treatment on microtubule detyrosination.
(A,B) Indirect immunofluorescence staining: OLN-t40-α-syn cells were left
untreated (A,a,B,a–c) or incubated with 40 µM LDN for 18 h (A,b,B,d–f). Cells
were subjected to indirect immunofluorescence staining using antibodies
against tyrosinated α-tubulin (tyr-tubulin; green) and detyrosinated tubulin
(detyr-tubulin; red). Nuclei were stained with DAPI (blue). Scale bar: 20 µm.
(C) Immunoblot analysis: OLN-t40-α-syn cells were incubated with 40 µM LDN
for 18 h. Co, untreated control. Cell lysates were subjected to immunoblot
analysis with the antibodies as indicated on the right. (D) Quantitative evaluation
of the blot shown in (C) was carried out using ImageQuant software. Data
represent the mean ± SD from three independent experiments. Tyr-tubulin and
detyr-tubulin levels were normalized to α-tubulin and the total amount of the
control was set to 100%. Statistical evaluation was carried out by Student’s
t-test: *p < 0.05 significant.
without interruptions. Similarly, detyrosinated dense bundles
of MTs are abundant within the cellular processes after LDN
treatment, while in control cells immunostaining with antibodies
against detyrosinated α-tubulin was detected mainly in the cell
soma and not in the cellular extensions or edges of the cells.
Detyrosination of α-tubulin has been linked to MT stability.
However, detyrosinated MTs are not stabilized by detyrosination
of α-tubulin per se, but this posttranslational modification
indirectly stabilizes MTs, because they are less susceptible
and protected from depolymerization (Fukushima et al., 2009;
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FIGURE 8 | Inhibition of UCH-L1 leads to the formation of GFP
positive autophagic vesicles. OLN-t40-α-syn-GFP-LC3 cells were
incubated with 40 µM LDN for 18 h (d–f). Untreated control (a–c).
(A) Cells were subjected to indirect immunofluorescence staining with
an antibody against α-tubulin (red). GFP, green. Overlay with DAPI
(blue). Scale bar: 20 µm. (B) Cells were subjected to indirect
immunofluorescence staining with an antibody against α-syn (red).
GFP, green. Overlay with DAPI (blue). The insert highlights the presence
of GFP-positive autophagic vesicles after LDN treatment. Scale bar:
20 µm.
Janke and Bulinski, 2011). Hence, blocking UCH-L1 has a
direct impact on the stability of the MT network by affecting
tubulin posttranslational modifications, i.e., acetylation and
tyrosination.
We were not able to detect ubiquitinated tubulin in our
system, which also may be due to a very low level of
ubiquitination. Only little is known about a possible role of
tubulin ubiquitination. The ubiquitin ligase parkin was suggested
to enhance the ubiquitination and degradation of misfolded α-
and β-tubulin (Ren et al., 2003). Bheda et al. (2010) showed
that UCH-L1 decreased the ability of tubulin to form MTs in
vitro, and overexpression of UCH-L1 in an SV40 transformed
fibroblastic cell line caused the reduction in MT assembly in
about 30% of transfected cells. Yet, the question remained
whether α- and β-tubulin were direct targets of ubiquitination
(Bheda et al., 2010). Low molecular weight MAPs could
also be involved in UCH-L1 mediated inhibition of tubulin
polymerization. However, we did not observe differences in the
action of LDN in the presence or absence of tau.
UCH-L1 binds to small polyubiquitinated proteins and
cleaves ubiquitin molecules, thus maintaining a stable mono-
ubiquitin pool, which is used for ubiquitination reactions (Todi
and Paulson, 2011; Ristic et al., 2014). Besides its hydrolase
activity, UCH-L1 can act as an E3 ligase responsible for
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FIGURE 9 | Inhibition of UCH-L1 in oligodendroglial cells induces
autophagy. (A) OLN-t40-α-syn-GFP-LC3 cells were incubated with 40 µM
LDN for 18 h (Co, untreated control). Cell lysates were subjected to immunoblot
analysis with the antibodies as indicated on the right. (B) Quantitative evaluation
of the blot shown in (A) was carried out using ImageQuant software. Data
represent the mean ± SD from three independent experiments. LC3-II and GFP
levels were normalized to α-tubulin and the total amount of the control was set
to 100%. Statistical evaluation was carried out by Student’s t-test: *p < 0.05
significant. (C) OLN-t40-α-syn-GFP-LC3 cells were left untreated (Co),
incubated with 40 µM LDN for 18 h, incubated with 3 nM bafilomycin A1 (Bf) for
20 h, or incubated with 3 nM Bf for 2 h followed by 40 µM LDN for 18 h. Cell
lysates were subjected to immunoblot analysis with the antibodies as indicated
on the right. (D) Quantitative evaluation of the blot shown in (C) was carried out
as described above. LC3-II and GFP levels were normalized to α-tubulin and
the total amount of the Bf treated cells were set to 100%. (E) OLN-t40-α-syn
cells and OLN-t40-A53T cells were incubated with 40 µM LDN for 18 h (Co,
untreated control). Cell lysates were subjected to immunoblot analysis with the
antibodies as indicated on the right. (F) Quantitative evaluation of the blot
shown in (E) was carried out as described above. LC3-II levels were normalized
to α-tubulin and the total amount of the control was set to 100%.
K63-linked polyubiquitination of α-syn, which may block
its proteasomal degradation (Liu et al., 2002). However, this
requires dimerization of UCH-L1 and so far has only been seen
in vitro. Ardley et al. (2004) described that after overexpression
of UCH-L1 in cultured neuronal and non-neuronal cell lines,
aggresomes were formed after proteasomal inhibition, which
were surrounded by an MT cage-like structure, and besides
UCH-L1 contained parkin and α-syn. This further sustains
the notion that UCH-L1 plays a pathological role in inclusion
formation, e.g., in PD, and may modulate the turnover of α-syn.
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Membrane associated UCH-L1 has been reported to promote
α-syn neurotoxicity by possibly negatively regulating the
lysosomal degradation of α-syn (Liu et al., 2009). Furthermore,
under pathological conditions, when α-syn was overexpressed,
blocking UCH-L1 by LDN resulted in an increase in LC3-II,
which was not observed in control cells, suggesting a differential
role of UCH-L1 activity under normal and pathological
conditions (Cartier et al., 2012). In oligodendroglial OLN cells
on the other hand, inhibition of UCH-L1 caused the induction
of the autophagic pathway even in the absence of α-syn.
Prefibrillary oligomers of α-syn have been hypothesized
to provide intermediates of fibrillary aggregates and
inclusion bodies, and to constitute the toxic species causing
neurodegeneration (Lansbury and Lashuel, 2006; Jellinger,
2009; Steiner et al., 2011; Kalia et al., 2013). α-Syn oligomers
can be degraded by lysosomal pathways (Lee et al., 2004), and
stimulating these pathways may be an effective therapeutic
approach to prevent α-syn accumulation and toxicity. In the
present cell culture system, the stable expression of α-syn
leads to small α-syn aggregates, which do not stain with
thioflavine S and represent non-fibrillar inclusions, which might
precede the formation of fibrillary deposits (Riedel et al., 2009).
Pharmacological inhibition of UCH-L1 attenuated the formation
of these aggregates by activating the lysosomal pathway. Using
GFP-LC3 expressing cells, we demonstrate that LDN increased
the level of LC3-positive autophagic vesicles and of free GFP.
Free GFP is generated by the degradation of GFP-LC3 within the
autolysosomes indicating that the autophagic flux is activated.
However, the total level of α-syn did not change, which points to
the conclusion that stimulation of the autophagic flux effectively
balanced the equilibrium of newly synthesized α-syn and
its degradation, which contributes to the clearance of small
oligomeric aggregates.
In summary, UCH-L1 is present in ODC and a constituent
of GCIs in MSA brains. Inhibition of UCH-L1 causes the
upregulation of autophagy, which is involved in the removal of
α-syn aggregates. Furthermore, UCH-L1 inhibition caused the
recruitment of detyrosinated and acetylated MTs to the cellular
processes, which promotes their stabilization and possibly their
association with dynein and kinesin motor proteins. This might
sustain transport processes required to efficiently deliver proteins
to the autophagic machinery. DUBs are central players in the
regulation of protein ubiquitination and the UPS and thus crucial
in many cellular regulatory mechanisms. Our data add to the
knowledge that the UPS and the autophagy-lysosomal pathway
are tightly balanced. DUB inhibitors provide a useful tool to
investigate the manifold functions of DUBs in nerve cells and
glia and to elucidate their dysregulation in neurodegenerative
diseases.
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